Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD3 | O94806 | 1/20 | 0.48 |
| ▸ | PRKCG | P05129 | 1/20 | 0.48 |
| ▸ | PRKCB | P05771 | 1/20 | 0.48 |
| ▸ | PRKCA | P17252 | 1/20 | 0.48 |
| ▸ | PRKCH | P24723 | 1/20 | 0.48 |
| ▸ | PRKCI | P41743 | 1/20 | 0.48 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.48 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.48 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.48 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.48 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.48 |
| ▸ | G6PD | P11413 | 4/20 | 0.45 |
| ▸ | TLR4 | O00206 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | CA9 | Q16790 | 3/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | MMP12 | P39900 | 1/20 | 0.38 |
| ▸ | XDH | P47989 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19273656 | 0.82 | PRKD3 (0.45) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL10291156 | 0.81 | G6PD (0.46) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL7150078 | 0.81 | PRKD3 (0.46) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL7146273 | 0.81 | PRKD3 (0.46) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL17253655 | 0.81 | PRKD3 (0.46) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL14175697 | 0.81 | PRKD3 (0.46) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL2320839 | 0.81 | PRKD3 (0.46) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL12038195 | 0.81 | PRKD3 (0.46) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL13752014 | 0.81 | PRKD3 (0.46) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL28205738 | 0.81 | PRKD3 (0.46) | PRKD3PRKCGPRKCBPRKCAPRKCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0944639-A4 | SYNTHETIC GLYCOAMINES, METHODS FOR THEIR USE THAT AFFECT CELL | GLINSKII GUENNADI V (US) | 2005-09-28 | — | — | EP | disclosed |
| WO-1999053930-A1 | SYNTHETIC GLYCOAMINES AND METHODS FOR THEIR USE, ALONE OR IN COMBINATION WITH OTHER THERAPIES, THAT AFFECT CELL ADHESION, INHIBIT CANCER CELL GROWTH AND METASTASIS, AND INDUCE APOPTOSIS | GLINSKII GUENNADI V (US) | 1999-10-28 | — | — | WO | disclosed |
| EP-0944639-A1 | SYNTHETIC GLYCOAMINES, METHODS FOR THEIR USE THAT AFFECT CELL | Glinskii, Guennadi, V. (US) | 1999-09-29 | — | — | EP | disclosed |
| WO-1998023625-A9 | SYNTHETIC GLYCOAMINES, METHODS FOR THEIR USE THAT AFFECT CELL | — | 1998-09-17 | — | — | WO | disclosed |
| WO-1998023625-A1 | SYNTHETIC GLYCOAMINES, METHODS FOR THEIR USE THAT AFFECT CELL | GLINSKII GUENNADI V (US) | 1998-06-04 | — | — | WO | disclosed |